Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 2

Sponsor Class

OTHER 15INDUSTRY 2OTHER_GOV 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 2550Triple Negative Breast Neoplasms 435Carcinoma, Non-Small-Cell Lung 338Ovarian Neoplasms 315Neoplasms 280Neoplasm Metastasis 253Colorectal Neoplasms 245Stomach Neoplasms 202Pancreatic Neoplasms 196Prostatic Neoplasms 188Lung Neoplasms 180Melanoma 171Squamous Cell Carcinoma of Head and Neck 140Endometrial Neoplasms 140Head and Neck Neoplasms 124Carcinoma, Renal Cell 118Uterine Cervical Neoplasms 104Esophageal Neoplasms 97Urinary Bladder Neoplasms 92Small Cell Lung Carcinoma 87Sarcoma 84Colonic Neoplasms 80Carcinoma, Hepatocellular 62Carcinoma, Transitional Cell 61Kidney Neoplasms 51Advanced Breast Cancer 51Cholangiocarcinoma 50Liver Neoplasms 47Brain Neoplasms 43Mesothelioma 37

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Chemotherapy-Related Cognitive Impairment × Breast × Clear all
NCT04839588 2022-04-28

TCIFCU

Bright Cloud International Corp

Completed
4 enrolled
Breast

Chemotherapy-Related Cognitive Impairment, Breast Neoplasms, Cognitive Dysfunction

NCT00387062 2008-06-24

Computer-Based Training in Patients With Post-Chemotherapy Cognitive Impairment

Posit Science Corporation

Phase 1 Completed
50 enrolled
Breast

Chemotherapy-Related Cognitive Impairment, Breast Neoplasms, Memory Disorders, Neurobehavioral Manifestations, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡